Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The emergence of the nanobiotechnology industry

Nature Nanotechnology volume 9, pages 2–5 (2014)Cite this article

Subjects

The confluence of nanotechnology and biotechnology provides significant commercial opportunities. By identifying, classifying and tracking firms with capabilities in both biotechnology and nanotechnology over time, we analyse the emergence and evolution of the global nanobiotechnology industry.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The emergence and evolution of the global nanobiotechnology industry.

References

  1. Lok, C. Nature 467, 18–21 (2010).

    Article  CAS  Google Scholar 

  2. Helmus, M. Nature Nanotech. 1, 157–158 (2006).

    Article  CAS  Google Scholar 

  3. Maine, E. Rev. Nanosci. Nanotechnol. 2, 300–305 (2013).

    Article  Google Scholar 

  4. Wagner, V., Dullart, A., Bock, A. & Zweck, A. Nature Biotechnol. 24, 1211–1217 (2006).

    Article  CAS  Google Scholar 

  5. Sharp, P. A. et al. The Third Revolution: The Convergence of the Life Sciences, Physical Sciences and Engineering (White Paper on Convergence, Massachusetts Institute of Technology, 2011).

    Google Scholar 

  6. Porter, A. L. & Youtie, J. Nature Nanotech. 4, 534–536 (2009).

    Article  CAS  Google Scholar 

  7. Simonton, D. K. Creativity in Science: Chance, Logic, Genius, and Zeitgeist (Cambridge Univ. Press, 2004).

    Book  Google Scholar 

  8. Maine, E., Thomas, V. J. & Utterback, J. J. Eng. Technol. Manage. http://dx.doi.org/10.1016/j.jengtecman.2013.10.007 (2013).

  9. Wang, J. & Shapira, P. Small Bus. Econ. 38, 197–215 (2012).

    Article  Google Scholar 

  10. Takeda, Y., Mae, S., Kajikawa, Y. & Matsushima, K. Scientometrics 80, 23–38 (2009).

    Article  CAS  Google Scholar 

  11. Maine, E. R&D Management 38, 359–371 (2008).

    Article  Google Scholar 

  12. Pisano, G. P. Ind. Corp. Change 19, 465–482 (2010).

    Article  Google Scholar 

  13. Maine, E., Bliemel, M., Murira, A. & Utterback, J. Mater. Res. Soc. Proc. 1466, http://dx.doi.org/10.1557/opl.2012.1199 (2012).

  14. AAAS Annual Meeting Session 5887 (2013); http://aaas.confex.com/aaas/2013/webprogram/Session5887.html

  15. Kellogg, S. Nature 472, 379–380 (2011).

    Article  Google Scholar 

  16. Porter, M. & Stern, S. MIT Sloan Manage. Rev. 42, 28–36 (2001).

    Google Scholar 

  17. Zucker, L. G., Darby, M. R. & Brewer, M. B. Am. Econ. Rev. 88, 290–306 (1998).

    Google Scholar 

  18. Utterback, J. M. Mastering the Dynamics of Innovation (Harvard Business Review Press, 1994).

    Google Scholar 

  19. Allen, T. M. & Cullis, P. R. Science 303, 1818–1822 (2004).

    Article  CAS  Google Scholar 

  20. Farokhzad, O. & Langer, R. ACS Nano 3, 16–20 (2009).

    Article  CAS  Google Scholar 

  21. Lewis, N. in AAAS Annual Meeting Paper 9351 (2013); http://aaas.confex.com/aaas/2013/webprogram/Paper9351.html

    Google Scholar 

  22. Sharp, P. A. & Langer, R. Science 333, 527 (2011).

    Article  CAS  Google Scholar 

  23. Bollinger, L., Hope, K. & Utterback, J. M. Research Policy 12, 1–14 (1983).

    Article  Google Scholar 

  24. Blank, R. in Forum for the Future of Higher Education 41–47 (Cambridge, 2011).

    Google Scholar 

Download references

Acknowledgements

The authors would like to thank the participants of the American Association for the Advancement of Science Annual Meeting 2013, the Beedie Innovation Conference 2013 and the Materials Research Society Spring Meeting 2012. In addition, the authors are grateful for funding from the Social Science and Humanities Research Council of Canada (Grant #410-2006-2270), from the Beedie School of Business at Simon Fraser University and from the David J. McGrath Jr (1959) Chair in Management and Innovation at the Sloan School of Management at MIT.

Author information

Authors and Affiliations

  1. Beedie School of Business, Simon Fraser University, Vancouver, Canada

    Elicia Maine & V. J. Thomas

  2. Australian School of Business, University of New South Wales, Sydney, Australia

    Martin Bliemel

  3. Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada

    Armstrong Murira

  4. Sloan School of Management, Massachusetts Institute of Technology, Cambridge, USA

    James Utterback

Authors
  1. Elicia Maine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. J. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Bliemel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Armstrong Murira
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. James Utterback
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elicia Maine.

Supplementary information

Supplementary Information

Supplementary Information (PDF 405 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maine, E., Thomas, V., Bliemel, M. et al. The emergence of the nanobiotechnology industry. Nature Nanotech 9, 2–5 (2014). https://doi.org/10.1038/nnano.2013.288

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nnano.2013.288

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research